Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00027105 · ClinicalTrials.gov registry record
Morbidity Following the Diagnosis and Treatment of Patients With Breast Cancer
A clinical trial, sponsored by National Institutes of Health Clinical Center (CC).
- Completed
- Registry status
- 165
- Enrollment target
NCT00027105 is a clinical trial that has completed, run by National Institutes of Health Clinical Center (CC). The registered enrollment target is 165 participants.
The verdict
NCT00027105 has completed, sponsored by National Institutes of Health Clinical Center (CC).
- COMPLETED
- Registry status
- 165 participants
- Enrollment target
Study Summary
This study will examine the frequency and severity of problems in women with breast cancer during the first year after initial medical treatment, including: * Physical impairments, such as loss of strength or flexibility, increased weight and swelling * Symptom distress, such as pain, fatigue and weakness. * Functional limitations and disabilities, such as loss of independence in activities of daily living (e.g., grooming, bathing, dressing, driving a car), work and social and recreational activities. It will identify factors associated with these problems and try to determine their relationship to them. Patients 18 years of age and older with stage I, II, III or IV breast cancer may be eligible for this study. Participants will be drawn from patients referred to the National Naval Medical Center for diagnosis and treatment during 2000-20001. Participants will be interviewed and their medical records reviewed for past medical history, history of the present illness and social and recreational history. They will be seen five times over a 1-year period (initial visit and at 3, 6, 9, and 12 months), for 30-minute visits, which will include the following: * Interview about past medical history and present illness, social and recreational activities, functional independence at work and during activities of daily living. * Complete health survey and upper limb disability questionnaire; physical activity questionnaire to be completed at 6 and 12 months after medical treatment begins. The questionnaires take about 30 to 40 minutes to complete. * Upper body examination, including pain measurement using a 10-point scale, an upper limb lift test, and measures of upper limb volume and girth.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 165 participants |
| Start Date | 2001-11-16 |
| Est. Completion | 2016-08-17 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00027105
The ClinicalTrials.gov registry entry for NCT00027105 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 165 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Institutes of Health Clinical Center (CC), which has 338 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00027105 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00027105 about?
NCT00027105 is a clinical study titled "Morbidity Following the Diagnosis and Treatment of Patients With Breast Cancer". This study will examine the frequency and severity of problems in women with breast cancer during the first year after initial medical treatment, including: * Physical impairments, such as loss of strength or flexibility, increased weight and swelling * Symptom distress, such as pain, fatigue and w...
What is the current status of trial NCT00027105?
This trial is currently completed. The enrollment target is 165 participants. The study started on 2001-11-16. Estimated completion is 2016-08-17.
Who is sponsoring clinical trial NCT00027105?
This trial is sponsored by National Institutes of Health Clinical Center (CC), which has 338 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.